Pluristem Heads for Two-Month High on $3.2 Million Israeli Grant

Pluristem Therapeutics Inc. (PSTI) headed for the highest close in more than two months after the developer of cell-therapy products said it received a grant of 11.8 million shekels ($3.2 million) from the Israeli government.

The shares advanced 2.2 percent to 9.38 shekels at 2:20 p.m. in Tel Aviv, poised for the highest close since Feb. 22. The shares have advanced 12.4 percent this month, trimming this year’s drop to 1.1 percent.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.